about
The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer.Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy.An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancerImmunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy.C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.Visualizing spatial distribution of alectinib in murine brain using quantitative mass spectrometry imagingShift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy.A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cells.Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.A case of synchronous bilateral breast cancer with different pathological responses to neoadjuvant chemotherapy with different biological character.Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer.Differential role of MACC1 expression and its regulation of the HGF/c‑Met pathway between breast and colorectal cancer.Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells.Clinical significance of CYLD downregulation in breast cancer.Osteopontin-integrin α(v)β(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma.Evaluation of the heterogeneous tissue distribution of erlotinib in lung cancer using matrix-assisted laser desorption ionization mass spectrometry imaging.Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis.Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression.MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer.Heterogeneous distribution of alectinib in neuroblastoma xenografts revealed by matrix-assisted laser desorption ionization mass spectrometry imaging: a pilot study.Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters.Stromal expression of neutrophil gelatinase-associated lipocalin correlates with poor differentiation and adverse prognosis in oral squamous cell carcinoma.Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging.[Effect of weekly paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide as neoadjuvant treatment for patients with triple-negative and luminal-type breast cancer - a multicenter study]Mucocele-like tumor associated with ductal carcinoma in situ diagnosed as mucinous carcinoma by fine-needle aspiration cytology: report of a caseClinical significance of pretherapeutic Ki67 as a predictive parameter for response to neoadjuvant chemotherapy in breast cancer: is it equally useful across tumor subtypes?Phosphoethanolamine Accumulation Protects Cancer Cells under Glutamine Starvation through Downregulation of PCYT2Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenograftsApplications of MALDI mass spectrometry imaging for pharmacokinetic studies during drug development
P50
Q33977133-7C8D5015-32DC-40C1-A68D-7C5750E727CEQ34227712-E2847116-4E0A-411E-B70A-2E8515D7C6EAQ34776985-B95CBE2C-5529-4CF7-B5ED-2B960A728213Q35159751-C7C05EFE-E73C-40A6-A96D-CD6642791CE5Q35722184-AFA25538-41AB-40DB-AE3D-599DA51AFDB6Q35973401-B2E4A77C-F748-4C53-9393-06863FA05C0AQ36135793-5668D1CB-37F1-4480-8940-642BA3E58C26Q36506949-B079B014-0CC9-4EDC-AC6C-EA62C0722FF5Q36801189-93AB434D-D5EE-43EA-99F9-47F8B1239DEFQ36965404-9F49597B-8EE9-4C1F-BB33-5BBB02B72B6DQ37328400-8B3C00DD-E2A1-40D1-902D-5B11E483B1F8Q38903636-9B4C7054-3628-46EF-A14F-427157ADC6C0Q38928700-59379215-C876-4239-9699-4A1C28787775Q39036670-1BBEDF95-86C2-49D7-8351-D11FED85B417Q41702715-0F7718A4-5D86-4316-9659-A2160FC667EEQ42282683-197FEFF0-A0FD-47AD-96F2-4BC4AC98D35CQ43280969-1799ECD7-720E-4531-BC3A-9142350EDD0AQ46014808-8A90E785-6C8D-4C37-B05B-BAB7D29BA921Q47114407-24295646-A9A3-47A7-9894-A09892B7616AQ47941822-1B20FCDA-0229-4456-B0BA-6A3F3D3CE05CQ48193794-89DE004C-4AD0-4EB9-836E-7ED960BA4BCEQ50132930-FA9B34A3-BE1A-4119-8E48-89201725A7BCQ54776761-4335D8FB-D11C-4E37-B5F2-482CF7E460F0Q54979887-D33A352B-4889-422C-A0E1-BC42933D1A7BQ57125385-26820E0A-D4D0-4D32-8A4C-81222A5E61A1Q83214762-CE7ACE8D-6A0E-4217-A326-B63644FE650CQ87384425-79E82010-4EF4-4135-B3EE-629CC26221A0Q90438691-26682E27-832F-46F6-9C79-A59E85DA6AEBQ92107306-6929283D-1F11-43D0-970B-265DF205ED89Q92123662-E0E0F9C8-FF39-4276-AF02-0A2CF3738206
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Mitsuhiro Hayashi
@en
Mitsuhiro Hayashi
@nl
type
label
Mitsuhiro Hayashi
@en
Mitsuhiro Hayashi
@nl
prefLabel
Mitsuhiro Hayashi
@en
Mitsuhiro Hayashi
@nl
P31
P496
0000-0001-6656-8502